Evidence map›Paper›PMID 31447834›Full record

ReviewFrontiers in immunology2019

The Endless Saga of Monocyte Diversity.

Stefania Canè, Stefano Ugel, Rosalinda Trovato, Ilaria Marigo, Francesco De Sanctis, Silvia Sartoris, Vincenzo Bronte

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 100 citations in OpenAlex.

  1. Review
  2. Immunity and Beyond: Emerging Roles of Monocytes and Macrophages in Cancer.Advances in experimental medicine and biology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Monocyte Involvement in the Pathogenesis of Myeloproliferative Neoplasms.International journal of molecular sciences · 2025
    Review
  8. Article
  9. Biochemistry and biophysics reports · 2025
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Characterization of Immunosuppressive Myeloid Cells in Merkel Cell Carcinoma: Correlation with Resistance to PD-1 Pathway Blockade.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Stefania CanèSection of Immunology, Department of Medicine, University of Verona, Verona, Italy.
Stefano UgelSection of Immunology, Department of Medicine, University of Verona, Verona, Italy.
Rosalinda TrovatoSection of Immunology, Department of Medicine, University of Verona, Verona, Italy.
Ilaria MarigoVeneto Institute of Oncology IOV-IRCCS, Padua, Italy.
Francesco De SanctisSection of Immunology, Department of Medicine, University of Verona, Verona, Italy.
Silvia SartorisSection of Immunology, Department of Medicine, University of Verona, Verona, Italy.
Vincenzo BronteSection of Immunology, Department of Medicine, University of Verona, Verona, Italy.
University of Verona · ITIstituto Oncologico Veneto · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer immunotherapy relies on either restoring or activating the function of adaptive immune cells, mainly CD8

Indexed as

AnimalsCCAAT-Enhancer-Binding Protein-alphaCell PlasticityHumansImmunotherapyMonocytesMyeloid-Derived Suppressor CellsNeoplasmsCCAAT-Enhancer-Binding Protein-alphametastatic nichemonocyte continuummonocytes heterogeneityprimary tumortargeting of monocytes

Identifiers

PMID31447834
PMCPMC6691342
OpenAlexW2961049678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.